Stockreport

Supernus Pharmaceuticals Inc (SUPN) Reports Robust Growth in Key Products for Full Year 2023 [Yahoo! Finance]

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com
PDF Total Revenue : Full year 2023 total revenues reached $607.5 million, with a non-GAAP increase of 26% excluding Trokendi XR net product sales. Operating Earnings : Op [Read more]